ABSTRACT. To examine the effect of prolactin (PRL) on transplacental water flow, we infused mannitol (500 ml; 20% solution) over 10 min into five chronically catheterized ewes (121-134 days' gestation), producing a peak maternal plasma osmolality by 10 min and fetal osmolality by 20 min. One day before or after, an identical amount of mannitol was infused into the same ewe during the 2nd h of a 2-h infusion of PRL (40 + 2.2 pg/h) into a fetal leg vein. Mean (2 SE) fetal plasma PRL levels were 6.9 + 3.2 ng/ml at baseline. Steady state fetal PRL levels were 17.7 2 7.4 ng/ml during PRL infusion. Maternal mannitol infused without administration of PRL to the fetus evoked a rise in fetal plasma osmolality similar to that following maternal mannitol during PRL administration to the fetus. Thus,.as shown previously, PRL affects water permeability across the membranous chorioamnion, whereas results of the present study indicate that the hormone does not affect water transfer across the ovine chorionic villi (placenta). 19: 986-988, 1985) Abbreviations AF, amniotic fluid PRL, prolactin AVP, arginine vasopressin
The importance of PRL in osmoregulation in fish and some mammals is well recognized. In these species PRL appears to act on several sites of hydromineral exchange including the fish gill, bladder, intestinal mucosa, and avian salt gland. Several recent studies also suggest that PRL plays a role in mammalian water homeostasis during pregnancy (1-1 1). PRL is found in high concentrations in human amniotic fluid (approximately 400 ng/ ml at term) although its function remains unclear. In pregnant women plasma PRL concentrations increase throughout gestation, with a return to basal levels by one week following delivery (I). PRL levels in human fetal plasma are relatively low before 25 wk but increase rapidly in the 3rd trimester; the mean value at term approximates 200 ng/ml (9) . In comparison to human AF levels, PRL levels are low in ovine amniotic fluid throughout gestation (approximately 10 ng/ml). PRL is present in ovine fetal blood in increasing concentrations from 90 days gestation with a sharp increase after 1 10 days gestation; at term the mean value has been reported to approximate 35 ng/ml (8, 9) . Thus, although there are quantitative differences, the ontogenic pattern for ovine fetal plasma PRL is similar to that of the human fetus.
PRL has been identified as one of the hormones affecting AF water dynamics. In vitro studies by Leontic and Tyson (6) , Holt and Perks (2), and Manku et al. (3) have shown that PRL affects diffusional water transfer across the isolated amniotic membrane, although the direction of this hormonally influenced water transfer may differ from species to species. Additionally, we have shown in vivo that elevated ovine AF PRL levels diminish bulk flow of water across the chorioamnion from the amniotic fluid to maternal circulation in response to acute changes in maternal osmolality (1 1). Also we have shown that following maternal mannitol infusion, fetal to maternal water transfer across the ovine placenta is diminished by fetal AVP or arginine vasotocin (10) . The object of the present study was to determine whether, like AVP and arginine vasotocin, fetal PRL affects osmotically induced (bulk flow) water transfer across the ovine chorionic villi (placenta) as it does across the membranous chorioamnion.
MATERIALS AND METHODS
Five date-bred healthy (Columbia-Suffolk) ewes with singleton fetuses of 116-126 days' gestation were studied. A maternal hysterotomy was camed out under ketamine anesthesia. A single fetal hind limb was exteriorized. Polyethylene catheters were inserted into the fetal dorsal leg vein and artery and advanced to the inferior vena cava and aorta, respectively. The fetus was then replaced in the uterus, the fetal catheters were exteriorized to a pouch attached to the flank of the ewe, and the uterus and maternal abdominal wall were closed. Maternal femoral venous and arterial catheters also were placed. Catheters were maintained patent with a dilute heparin solution. At least 5 days were allowed for recovery from surgery. Chloramphenicol (250 mg) was given intravenously to the ewe and instilled into the amniotic cavity (250 mg) twice daily. Animals were maintained in indoor pens and allowed access to baled alfalfa and water ad libitum. Gestational age at the time of studies ranged from 12 1-134 days.
On the day of study, drinking water was removed from the cage. Studies were conducted only if the fetal arterial pH exceeded 7.3. Twenty-four ml whole blood were removed from the maternal circulation into a heparinized syringe for subsequent fetal replacement transfusion.
In protocol I (mannitol control), three baseline blood samples (3 ml each) were obtained at 10-min intervals from both fetal and maternal arterial catheters for plasma osmolality determinations. All samples were collected only after three times the dead space volume of the catheter (1 and 2 ml, fetal and maternal, respectively) was withdrawn. After baseline blood samples were obtained, 500 ml mannitol were infused via the maternal venous catheter over 10 min. After the completion of the mannitol infusion, five (3 ml) blood samples were obtained from the WATER TRANSFER IS INDEPENDENT OF FETAL PRL 987 maternal and fetal arterial catheters at 10-min intervals. Throughout the study, each maternal sample was replaced with an equal quantity of isotonic saline; each fetal sample was replaced with an equal volume of maternal heparinized whole blood prepared prior to the study, and the dead space volume of fetal blood and flush solution was reinfused.
One day before or after the protocol I study, protocol I1 (mannitol during fetal PRL infusion) was performed in the same animals. After obtaining three baseline blood samples at 10-min intervals, ovine PRL [Ovine PRL, National Institutes of Health, (lot no. 14), Bethesda, MD] (40 f 2.2 pglh) was infused for 2 h into the fetal vein. Blood samples (3 ml each) were obtained every 10 min from both the fetus and ewe throughout the PRL infusion period, with blood replacement as described previously. At the completion of the 1st h of the fetal PRL infusion, mannitol was infused into the mother ewe via the femoral venous catheter in a manner identical to protocol I.
Both fetal and maternal blood samples (3 ml) were collected in iced tubes containing 15% EDTA. Samples were centrifuged and the plasma separated. One-ml plasma samples were stored at -20" C for measurement of osmolality determined by freezing point depression using an Advanced Instruments 3R Precision Osmometer. The remaining plasma was stored at -20" C for measurement of plasma sodium levels by flame photometry and plasma prolactin by radioimmunoassay (12, 13) . Ovine PRL concentrations were determined by radioimmunoassay utilizing purified ovine PRL and antisera obtained from the National Institute of Arthritis, Diabetes and Kidney Disease. National Institute of Arthritis, Diabetes and Kidney Disease oPRL-I-1 was used both as standard and for iodination. The oPRL was iodinated with NaI2'I and Iodogen (Pierce Chemical Co.) and the labeled fraction was separated using Sephadex G-75 (Pharmacia). National Institute of Arthritis, Diabetes and Kidney Diseaseanti-oPRL-1 antiserum was used as the first antibody.
Mean values for the baseline and poststimulation (postmannitol) study periods were compared using the paired t test. Comparisons between groups for protocols I and I1 were made by 2-way analysis of variance. Values were expressed as mean + SEM.
RESULTS
The baseline (mean + SEM) fetal plasma PRL level was 6.9 f 3.2 ng/ml. The mean infusion steady state plasma oPRL level was 17.7 f 7.4 ng/ml. Figure 1 shows the fetal osmolal response to maternal mannitol infusion with and without concurrent fetal PRL infusion. In protocol I, mean (+. SEM) fetal baseline os- In the present study fetal PRL infusions produced plasma PRL levels approximately double baseline fetal PRL concentrations. Thus we produced physiologic rather than pharmacologic plasma PRL levels (8) . Although plasma levels of PRL have been measured previously in the chronically catheterized ovine fetus (S), PRL receptors have been identified only in cell membranes of a variety of adult rhesus monkey tissues, including liver, lung, myocardium, and placenta. Less is known about ovine PRL receptors. Ovine PRL receptors are likely, however, since we previously reported that amniotic to maternal water transfer across the chorioamnion in response to a maternal osmotic challenge is diminished in the presence of elevated AF PRL levels (1 1). In the rhesus monkey high levels of PRL in AF: I) tend to minimize any increase in fetal electrolyte concentration during conditions of experimentally induced hypertonicity, and 2) inhibit fetal losses of electrolytes and water when AF hypotonicity is induced (5) . In contrast, Leontic and Tyson (7) reported that maternal to fetal transport of tritiated water is not affected in vitro by PRL. Moreover, AF PRL has little or no effect on water transport by fetal skin (7) . Additionally, in the present study elevated fetal PRL levels had no apparent effect on transplacental flow of water from the fetal to the maternal circulation (presumably at the level of the chorionic villi "placenta") in response to acutely induced maternal plasma hyperosmolality. These data, in total, suggest that the primary osmoregulatory site of action for PRL may be the membranous chorioamnion.
The PRL used for these studies is known to be contaminated with minimal amounts of AVP; however Leontic and Tyson (7) have shown that AVP in concentrations far exceeding those contaminating ovine PRL preparations does not affect water transport (6) .
This study explores another site of possible fetal hormonal influence on fetal/maternal/amniotic fluid water exchange in the mammal. The site(s) of action and the precise effects of various hormones may vary from species to species, perhaps depending on the type of placenta, ontogenic pattern of hormonal secretion, receptor sites, and other factors. In the ewe, however, the most convincing site of PRL effect appears to be the membranous chorioamnion.
